![](/img/cover-not-exists.png)
SLV310, a molecule combining potent dopamine D2 receptor antagonism with serotonin reuptake inhibition, active in preclinical models for antipsychotic as well as anxiolytic activity
T. Tuinstra, A.H.J. Herremans, J.A.M. Van der Heyden, A.C. McCreary, M.B. Hesselink, C.G. Kruse, S.K. LongVolume:
12
Year:
2002
Language:
english
DOI:
10.1016/s0924-977x(02)80426-6
File:
PDF, 131 KB
english, 2002